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Immunotoxicity and allergic potential induced by topical 
application of dimethyl carbonate (DMC) in a murine model
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Abstract
Dimethyl carbonate (DMC) is an industrial chemical, used as a paint and adhesive solvent, with 
the potential for significant increases in production. Using select immune function assays, the 
purpose of these studies was to evaluate the immunotoxicity of DMC following dermal exposure 
using a murine model. Following a 28-day exposure, DMC produced a significant decrease in 
thymus weight at concentrations of 75% and greater. No effects on body weight, hematological 
parameters (erythrocytes, leukocytes, and their differentials), or immune cell phenotyping (B-
cells, T-cells, and T-cell sub-sets) were identified. The IgM antibody response to sheep red blood 
cell (SRBC) was significantly reduced in the spleen but not the serum. DMC was not identified to 
be an irritant and evaluation of the sensitization potential, conducted using the local lymph node 
assay (LLNA) at concentrations ranging from 50–100%, did not identify increases in lymphocyte 
proliferation. These results demonstrate that dermal exposure to DMC induces immune 
suppression in a murine model and raise concern about potential human exposure and the need for 
occupational exposure regulations.
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Introduction
Dimethyl carbonate (DMC), also referred to as carbonic acid, dimethyl ester, and methyl 
carbonate, is an industrial chemical with promising new and useful applications across a 
broad range of markets. DMC is an organic compound, classified as a carbonate ester with 
the formula OC(OCH3)2. It is readily hydrolyzed to carbon dioxide and methanol in the 
environment and presumably in the body via esterases, where methanol is subsequently 
metabolized to formaldehyde, which is further oxidized to formic acid (OEHHA, 2010). It is 
a high volume chemical, with production exceeding 1 million pounds annually in the US; 
Kowa Corporation has proposed use to potentially increase from 2–5 million pounds per 
year (OEHHA, 2010). It is a colorless, fast evaporating solvent with a substantial polar 
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nature and moderate hydrogen-bonding strength which could be effective in replacing esters, 
glycol ethers, and ketones in formulations. In addition to being a solvent, it has potential 
uses as a methylating agent and as a chemical intermediate for use in the production of 
diphenyl carbonate, isocyanate, allyl diethylene, glycol carbonate, and carbamate pesticides. 
There is also interest in using this compound as a fuel oxygenate additive and as a solvent of 
lithium battery electrolytes in the battery industry (Li et al., 2009; Inamoto et al., 2012).
More recently, the use of DMC as a solvent has increased because of its exemption from 
classification as a volatile organic compound (VOC) under the Clean Air Act in 2009 by the 
US EPA (2009). This ruling was based on DMC not being classified as a hazardous air 
pollutant and its low ozone-forming potential. With the growing awareness of environmental 
protection, low-pollution products with low toxicity have become the trend. The 
manufacture of solvent-based paints requires a large number of organic solvents, most of 
which have some degree of toxicity, including: aliphatic hydrocarbons, aromatic 
hydrocarbons, esters, ketones, and alcohols. DMC has been proposed as a low-toxicity 
solvent for paints, inks, and adhesives which could replace the currently used and toxic 
toluene, ethyl acetate, and butyl acetate (American, 2009).
DMC is also readily biodegradable, with a low potential to bio-accumulate or be persistent 
in the environment (Memoli et al., 2001; Miao et al., 2008); this allows it to be considered as 
a green reagent. Because of this classification DMC has grown in popularity for use in select 
applications and as a replacement for other solvents such as methyl ethyl ketone, tert-butyl 
acetate, and parachlorobenzotrifluoride (American, 2009), and other methylating reagents 
including phosgene, methyl chloroformate, iodomethane, and dimethyl sulfate (Fabbri et al., 
2005).
In spite of the non-toxic claims for DMC, studies describing its toxicity are limited. No 
long-term, chronic exposure studies have been conducted. DMC was identified to have low 
acute oral toxicity (LD50 rat = 12,900 mg/kg, LD50 mouse = 6000 mg/kg) and found to be 
negative in mutagenicity tests (i.e., in vitro Ames and Comet assays) conducted in L-929 
mouse fibroblasts (Song, 2002). In a 10-day developmental toxicity study, mated female 
mice were exposed by inhalation to concentrations of DMC up to 3000 ppm during gestation 
days 6–15 for 6 h/day (Exxon Corporation, 1992; Bevan, 1995). Maternal and fetal body 
weights were reduced and the number of growth-stunted and malformed fetuses was 
increased at 3000 ppm. The No Observed Adverse Effect Level (NOAEL) for maternal and 
developmental toxicity was determined to be 1000 ppm, virtually identical to the main 
metabolite of DMC, methanol (NOAEL = 1000 ppm) (Rogers et al., 1993). From the very 
limited human data, DMC is suspected to be mildly toxic by ingestion (Lewis, 1996; HSDB, 
2009). No other data were available in the peer-reviewed literature for chronic exposure of 
humans to DMC. There is, however, toxicity data available for the metabolites of DMC 
(methanol, formaldehyde, and formic acid) (NTP, 1992; ATSDR, 1999; NTP-CERHR, 
2003).
Due to the high production volume of this chemical, there is the potential for exposure of 
workers and the general public located near facilities where DMC is used. While DMC is 
described as a non-toxic alternative, aside from acute toxicity studies, no other organ-
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specific toxicities have been examined and the MSDS sheet states that the toxicological 
properties of this chemical have not been tested. The recent increase in occupational use, 
along with the potential for dermal exposure, raise concerns about related adverse health 
effects. The purpose of these studies was to determine the immunotoxicity following dermal 
exposure to DMC using a murine model.
Materials and methods
Test articles and chemicals
Dimethyl Carbonate (DMC; Figure 1) [CAS #616-386], α-hexylcinnamaldehyde (HCA) 
[CAS# 101-86-0], 2,4-dinitrofluorobenzene (DNFB) [CAS# 70-34-8], and 
cyclophosphamide [CP; CAS# 50-18-0] were purchased from Aldrich Chemical Company, 
Inc. (Milwaukee, WI).
Species selection
Female BALB/c and B6C3F1 mice were used in these studies. BALB/c mice have a T-helper 
(TH)-2 bias and are commonly used to evaluate potential IgE-mediated sensitization and 
were therefore used in the hypersensitivity studies (Woolhiser et al., 2000; Klink and 
Meade, 2003). B6C3F1 mice are the strain of choice for immunotoxicity studies and were 
used to evaluate the IgM response to sheep red blood cells (SRBC) (Luster et al., 1992a, b).
All mice were purchased from Taconic (Germantown, NY) at 6–8 weeks-of-age. Upon 
arrival, the animals were allowed to acclimate for a minimum of 5 days. Each shipment of 
animals was randomly assigned to a treatment group, weighed, and individually identified 
via tail marking using a permanent marker. A preliminary analysis of variance on body 
weights was performed to insure an homogeneous distribution of animals across treatment 
groups. The animals were housed at a maximum of five mice/cage in ventilated plastic 
shoebox cages with hardwood chip bedding. NIH-31 modified 6% irradiated rodent diet 
(Harlan Teklad) and tap water was provided from water bottles, ad libitum. The temperature 
in the animal facility was maintained between 68–72°F and the relative humidity between 
36–57%; a light/dark cycle was maintained at 12-h intervals. All animal experiments were 
performed in an Association for Assessment and Accreditation of Laboratory Animal Care 
(AAALAC) accredited National Institute for Occupational Safety and Health (NIOSH) 
animal facility in accordance with an animal protocol approved by the Institutional Animal 
Care and Use Committee.
Concentration range-finding studies
Concentration range-finding studies were performed to select the concentrations of DMC to 
be used for dermal exposures. BALB/c mice were exposed topically to acetone vehicle or 
increasing concentrations of DMC in acetone on the dorsal surface of each ear (25 μl per 
ear) for three consecutive days. Animals were allowed to rest for 2 days following the last 
exposure and then weighed and examined for signs of toxicity, such as loss of body weight, 
fatigue/lack of activity, and ungroomed fur. DMC was tested at concentrations up to 100%. 
The maximum concentration selected for the subsequent studies was based on limits of 
toxicity.
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For the hypersensitivity study, BALB/c mice (five mice/group) were topically treated with 
acetone vehicle, increasing concentrations of DMC or positive control [30% HCA (v/v; 
sensitization positive control) and 0.3% DNFB (v/v; irritancy positive control)] on the dorsal 
surface of each ear (25 μl per ear) once a day for three consecutive days. For the immune 
phenotyping and hematology studies, B6C3F1 mice (n = 5) were topically exposed to 
acetone or increasing concentrations of DMC (up to 100%) topically on the shaved backs 
(50 μl) once a day for 28 consecutive days. For analysis of the IgM response to SRBC, 
B6C3F1 mice (n = 6) were topically exposed to acetone or increasing concentrations of 
DMC (up to 100%) topically on the shaved backs (50 μl) once a day for 28 consecutive 
days. Cyclophosphamide (20 mg/kg in isotonic sterile saline) was included as the positive 
control for the analysis of the IgM response to SRBC and was injected intraperitoneally 4 
days prior to sacrifice.
Combined local lymph node and irritancy assay
To determine the irritancy and sensitization potential of DMC, a combined local lymph node 
assay (LLNA) was conducted. DMC dosing concentrations (50–100%) and vehicle 
(acetone) were selected based solubility and preliminary concentration range finding studies. 
A combined LLNA was performed according to the methods previously described in 
Anderson et al. (2007).
Phenotypic analysis of splenocytes
Spleen phenotypes were analyzed using flow cytometry, as described by Manetz and Meade 
(1999). Animals were euthanized by CO2 inhalation 24 h after the final exposure, weighed, 
and examined for gross pathology. Blood was collected in EDTA-coated vacutainer tubes 
following transection of the abdominal aorta and hematological analysis was conducted (see 
below). The liver, spleen, kidneys, and thymus were removed, cleaned of connective tissue 
and weighed. For phenotypic analysis, the spleen was collected in 3 ml phosphate-buffered 
saline (PBS, pH 7.4) and dissociated using the frosted ends of two microscope slides. Cell 
counts were performed using a Coulter Counter (Z2 model, Beckman Coulter, Brea, CA), 
and 1 × 106 cells per sample were added to the wells of a 96-well plate. Cells were washed 
using staining buffer (1% bovine serum albumin/0.1% sodium azide in PBS) and then 
incubated with Fc block (clone 2.4G2; BD Pharmingen, San Diego, CA). For analysis of T-
cell sub-sets, cells were then treated with 100 µl of anti-mouse CD3e (APC, clone 
145-2C11), anti-mouse CD4 (FITC, clone RM4-5), and anti-mouse CD8a (PE, clone 53-6.7) 
antibody solutions; for analysis of B-cells, cells received anti-mouse CD45R/B220 antibody 
(FITC, clone RA3-6B2). Parallel sets of cells received appropriate isotype controls diluted 
in staining buffer. All antibodies and isotype controls were purchased from BD Pharmingen. 
The cells were then incubated on ice in the dark for 30 min. The cells were then washed and 
incubated with propidium iodide (PI). After a final wash, cells were re-suspended in staining 
buffer and analyzed with a Becton Dickinson LSR II flow cytometer using a PI viability 
gate; all assays were performed using the FACS DIVA software accompanying the flow 
system. For each sample, a minimum of 10,000 events was acquired.
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Selected hematological parameters were evaluated using a Hemavet 950 automatic 
hematology analyzer (Drew Scientific, Waterbury, CT). End-points analyzed included 
peripheral erythrocyte and leukocyte counts, leukocyte differentials (lymphocytes, 
neutrophils, monocytes, basophils, and eosinophils), platelet counts, hematocrit, hemoglobin 
levels, mean corpuscular hemoglobin (MCH) and hemoglobin concentration (MCHC), mean 
corpuscular volume (MCP), mean platelet volume (MCV), and platelet distribution width 
(PDW).
Spleen in vivo response to the T-cell-dependent antigen SRBC
The primary IgM response to sheep red blood cells (SRBC) was enumerated using a 
modified hemolytic plaque assay of Jerne and Nordin (1963). Four days prior to euthanasia 
(i.e., Day 29), the mice were immunized with 7.5 × 107 SRBC (in 200 µl volume) by 
intravenous injection. All SRBC for these studies were drawn from a single donor animal 
(Lampire Laboratories, Pipersville, PA). On the day of sacrifice, mice were euthanized by 
CO2 asphyxiation, body and organ weights were recorded, and spleens were collected in 3 
ml of Hank’s balanced salt solution (HBSS). Blood was also retrieved in serum collection 
tubes following transection of the abdominal aorta and stored at −20°C for subsequent 
analysis of serum anti-SRBC IgM levels (see below).
Single cell suspensions of the spleens from individual animals were prepared in HBSS by 
disrupting the spleen between the frosted ends of microscopic slides. To identify the total 
number of spleen cells, 20 μl of cells were added to 10 ml of Isoton II diluent (1:500; 
Beckman Coulter) and two drops of Zap-o-globin (Beckman Coulter) were added to lyse red 
blood cells. Cells were then counted in the Coulter counter. Dilutions (1:30 and 1:120) of 
spleen cells were then prepared, and 100 μl of each dilution were added to test tubes 
containing a 0.5 ml warm agar/dextran mixture (0.5% Bacto-Agar, DIFCO; and 0.05% 
DEAE dextran; Sigma, St. Louis, MO), 25 μl of 1:1 ratio of SRBC suspension, and 25 μl of 
1:4 dilution (1 ml lyophilized) guinea pig complement (Cedarlane Labs, Burlington, 
Canada). Each sample was vortexed, poured into a petri dish, covered with a microscope 
coverslip, and incubated for 3 h at 37°C. The plaques (representing antibody-forming B-
cells) were then counted. Results were expressed in terms of both specific activity (IgM PFC 
per 106 spleen cells) and total activity (IgM PFC per spleen).
Serum IgM response to SRBC
Serum samples were analyzed for anti-SRBC IgM using a commercially available ELISA 
kit (Life Diagnostics, West Chester, PA), according to manufacturer recommendations with 
modifications. Test serum was diluted (1:200, 1:400, 1:800, and 1:1,600) and incubated in 
the micro-titer wells for 45 min at 25°C. The wells were subsequently washed, 100 µl horse-
radish peroxidase-conjugated secondary antibody was added, and the plates incubated for a 
further 45 min at 25°C. Thereafter, the wells were washed to remove unbound antibodies, 
and 100 µl tetramethylbenzidine peroxidase (TMB) reagent was added to each well. The 
plates were then incubated for 20 min at room temperature before color development was 
stopped by the addition of 50 µl of kit-provided Stop Solution. Optical density in each well 
was then measured spectrophotometrically at 450 nm using a Spectra Max M2 plate reader 
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(Molecular Devices, Sunnyvale, CA). The concentration of the anti-SRBC IgM in the test 
samples was determined by comparison to a standard curve generated in parallel using 
SoftMax Pro software, and reported as units of anti-SRBC IgM (U/ml) plotted vs 
absorbance values at 450 nm.
Statistical analyses
For analysis of the data generated from the described animal studies, the data were first 
tested for homogeneity using the Bartlett’s Chi Square test. If homogeneous, a one-way 
analysis of variance (ANOVA) was conducted. If the ANOVA showed significance at p < 
0.05 or less, the Dunnett’s Multiple Range t-test was used to compare treatment groups with 
the control group. Linear trend analysis was performed to determine if DMC had exposure 
concentration-related effects for the specified end-points. Statistical analysis was performed 
using Graph Pad Prism version 5.0 (San Diego, CA). Statistical significance against value 
for 0% DMC samples is designated by * p ≤ 0.05 and ** p ≤0.01.
Results
In vivo studies did not identify DMA to be an allergic sensitizer or dermal irritant
Dermal exposure to DMC was not found to be toxic at any concentration tested (data not 
shown). For this reason, concentrations of DMC up to 100% were tested in the subsequent 
studies. No ear swelling was observed in mice after dermal exposure to DMC (Figure 2a). 
DNFB (0.3%) was used as a positive control for irritancy studies and resulted in an average 
significant increase of 145% in ear swelling post-application. No increase in auricular 
draining lymph node proliferation was identified after treatment with DMC (Figure 2b). 
HCA (30%) was used as a positive control for these experiments and resulted in an average 
SI value of 9.8.
Dermal exposure to DMC for 28 days results in reduced thymus weights
In contrast to body weight data, a statistically significant decrease in thymus weights was 
observed following exposure to 100% DMC (Table 1). No other significant changes in body 
or organ weight were observed following exposure to any concentration of DMC (Table 1). 
Although not statistically significant, there was a slight decrease in spleen weight. Dermal 
exposure to DMC did not alter any of the analyzed hematological parameters (Table 2), 
splenocyte numbers, or subpopulations (Table 3).
Dermal exposure to DMC suppressed the splenic—but not serum—IgM response to SRBC
To evaluate if exposure to DMC was immunosuppressive, the murine IgM response to 
SRBC was examined following a 28-day exposure to DMC. Statistically significant 
reductions in the PFC/spleen and specific (PFC/106 cells) IgM antibody activity against 
SRBC were observed after exposure to DMC (Figures 3a and b). Exposure of mice to 100% 
DMC resulted in a suppression of the values for PFC/spleen and PFC/106 cells (33 and 46%, 
respectively, vs values for vehicle-treated mice); 50% DMC resulted in suppressions of 
PFC/spleen (38%) and PFC/106 cells (43%) (Figure 3). While mice exposed to 75% DMC 
did not have a statistically significant reduction in antibody production, the levels appeared 
to be reduced compared to those associated with the vehicle controls. Mice exposed to 
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cyclophosphamide had a significantly reduced specific spleen IgM response (78%) and total 
IgM response (76%) compared to levels noted in vehicle-treated controls. There was no 
change in serum anti-SRBC IgM antibody levels following exposure to DMC; however, 
cyclophosphamide (positive control) suppressed the antibody response by 66% relative to 
control mice values (Figure 4).
Discussion
More than 13 million workers in the US are potentially exposed to chemicals that can be 
absorbed through the skin. Exposures to chemical substances may induce immune 
abnormalities including immune suppression and autoimmunity, potentially compromising 
the ability of the immune system to recognize or neutralize infectious agents or neoplastic 
cells. There is an increasing need for the immunological evaluation of exposure to these 
chemicals and/or substances due to the potential risk for the development of clinical disease.
In an attempt to fill some of the data gaps associated with DMC exposure-related health 
effects, the immunotoxicity of DMC was evaluated using a murine model in the studies 
described here. The results from these studies suggest that DMC is a non-irritating and non-
sensitizing chemical, as evidenced by the lack of increase in ear swelling and lymphocyte 
proliferation. However, suppression of the IgM response to SRBC and reduced thymus 
weights were observed following a 28-day exposure to this chemical. Statistically significant 
suppression was observed at 50% and 100% concentrations for the specific activity, while 
only at 50% for the total activity. Although the antibody response was reduced at the 75% 
concentration, it was not statistically significant. Based on the lack of concentration dose 
response and the linearity between exposure group responses, the threshold for suppression 
may be at a maximum following exposure to concentrations of DMC of 50% and greater.
The T-cell dependent antibody response is one of the most sensitive indicators of immune 
integrity because it relies on an organized immune response that is dependent on the 
functional capacity and co-operation of numerous cell types including B-cells, T-cells, and 
macrophages (Anderson et al., 2006). Immunosuppression determined by the spleen IgM 
response to SRBC (plaque assay) was observed, but the serum IgM response to SRBC was 
not decreased. Although the mechanism underlying the contradictory results between the 
splenic PFC response and serum IgM titers to SRBC is unknown, it has been observed 
following exposure to other chemicals (Hsieh et al., 1989; Temple et al., 1993; Johnson et 
al., 2000). The differences in sensitivities may be attributed to the specific end-points that 
each assay measures. The plaque assay enumerates antibody-producing cells in the spleen, 
while the ELISA method measures IgM levels in the serum that may be produced in the 
spleen as well as the lymph nodes and bone marrow. It has also been determined that the 
murine spleen PFC response to SRBC peaks on day 4 after immunization, while the serum 
IgM response peaks between days 5 and 6 (Loveless et al., 2007). It should also be noted 
that, in our studies, the spleen and serum were both collected on the same day (i.e., Day 4) 
after immunization.
Although exposure to DMC can occur through inhalation and dermal contact during its 
production and use, there are currently no Occupational Safety and Health Administration 
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(OSHA)-, National Institute for Occupational Safety and Health (NIOSH)-, or American 
Conference of Governmental Industrial Hygienists (ACGIH)-recommended or required 
exposure limits. This lack of regulation is in spite of expanded use of DMC that has led to a 
greater potential for worker exposure. It is important to note that although the concentrations 
of DMC evaluated in the studies described here were high (50–100%), neat exposure is 
often required for solvents. In an attempt at regulation, the manufacturer Kowa American 
has set forth a recommended 8-h personal exposure limit (PEL) of 100 ppm based on OSHA 
and ACGIH exposure limits for methanol—the expected primary metabolite of DMC.
It has been proposed that DMC would replace some of the more toxic paint solvents, 
including toluene, ethyl acetate, and butyl acetate. Hsieh et al. (1989, 1990) evaluated the 
immunotoxic effect of toluene exposure via drinking water in mice. Similar to what was 
noted with DMC, decreases in thymus weight and suppression of the spleen but not serum, 
IgM response to SRBC were observed. There were no changes in body weights or 
hematological parameters following exposure to toluene. Based on a scheme proposed by 
van Loveren and colleagues that classifies immunotoxic chemicals based on the affected 
immune responses (i.e., antibody response, organ weights), toluene and DMC would both be 
categorized as weak immunotoxic agents (Veraldi et al., 2006). Comparable to the DMC 
developmental toxicity studies, whole body inhalation exposure of rats (gestation day 6–20, 
at 6 h/day) to concentrations of butyl acetate (up to 3000 ppm) resulted in decreased 
maternal weight gain and food consumption (Saillenfait et al., 2007). However, while DMC 
resulted in developmental effects, for butyl acetate, fetal effects were limited to a decreased 
fetal weight at the 3000 ppm exposure level. A 13-week butyl acetate rat inhalation study 
also demonstrated decreased body weight, feed consumption, liver, kidney, and spleen 
weights at concentrations of ≥ 1500 ppm for male rats (David et al., 2001). Acute toxicity 
and cancer risk assessment for butyl acetate suggest it is a potential carcinogen (Budroe et 
al., 2004). Limited toxicity data (LD50 rats = 11.3 g/kg) was found for ethyl acetate. Given 
the similarities between DMC and other commonly used industrial solvents, it is 
questionable if it really is a non- or less toxic alternative.
These are the first studies to evaluate the allergic potential and immunotoxicity induced by 
dermal exposure to DMC using a murine model. Although significant data gaps still exist for 
the complete toxicological evaluation of this chemical, these results suggest that DMC, 
when evaluated in a murine model, is an immunotoxic chemical. The results presented here, 
along with the increasing production demands for this chemical, raise concern for the need 
for additional, long-term exposure studies. In an effort to reduce and prevent occupational 
exposure and potential disease, regulations for the use of this chemical may also need to be 
considered.
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Chemical structure of DMC.
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Irritancy and allergic sensitization potential after dermal exposure to DMC. Analysis of the 
(a) irritancy and (b) allergic sensitization potential of DMC using the combined irritancy/
LLNA. DPM represent [3H]-thymidine incorporation into draining lymph node cells of 
BALB/c mice following exposure to vehicle or concentration of DMC. Bars represent mean 
(± SE) of five mice (10 ears; irritancy) per group. Levels of statistical significance are 
denoted (** p < 0.01) as compared to acetone vehicle.
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DMC suppresses the spleen IgM response to SRBC. Analysis of antibody producing spleen 
cells after a 28-day dermal exposure to DMC suppressed the (a) total and (b) specific 
activity IgM response to SRBC. Bars represent mean fold-change (± SE) of six mice per 
group. Cyclophosphamide (CP) was included as the positive control.
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DMC exposure does not alter the serum IgM response to SRBC. Analysis of serum after a 
28-day dermal exposure to DMC did not produce alternations in IgM response to SRBC. 
Bars represent mean fold-change (± SE) of six mice per group. Cyclophosphamide (CP) was 
included as the positive control.
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Table 1
Body/organ weights of female B6C3F1 mice dermally exposed to dimethyl carbonate for 28 days.
Dimethyl carbonate
Parameter 0% 50% 75% 100%
Body weight (g) 21.61 ± 0.40 20.79 ± 1.10 22.33 ± 1.17 22.07 ± 1.02
Kidney weight (mg) 259 ± 5 264 ± 18 284 ± 15 272 ± 9
% bw 1.19 ± 0.01 1.27 ± 0.03 1.28 ± 0.08 1.23 ± 0.00
Spleen weight (mg) 88 ± 17 75 ± 5 74 ± 4 67 ± 4
% bw 0.41 ± 0.09 0.36 ± 0.01 0.33 ± 0.02 0.30 ± 0.02
Thymus weight (mg) 55 ± 2 50 ± 2 44 ± 3* 40 ± 3**
% bw 0.26 ± 0.01 0.24 ± 0.02 0.20 ± 0.02 0.18 ± 0.02*
Liver weight (mg) 1123 ± 74 1013 ± 65 1090 ± 62 1034 ± 60
% bw 5.20 ± 0.38 4.90 ± 0.07 4.90 ± 0.31 4.70 ± 0.15
bw, body weight.
Values are expressed as means (± SE) for each group.


















Anderson et al. Page 16
Table 2
Hematology parameters of female B6C3F1 mice dermally exposed to dimethyl carbonate for 28 days.
Dimethyl carbonate
Parameter 0% 50% 75% 100%
Hemoglobin (g/dl) 13.84 ± 0.26 12.82 ± 0.79 13.50 ± 0.63 13.84 ± 0.76
Erythrocytes (M/μl) 8.96 ± 0.22 8.35 ± 0.50 8.59 ± 0.43 8.85 ± 0.50
Platelets (K/μl) 291 ± 131 471 ± 92 297 ± 101 384 ± 63
Hematocrit (%) 47.36 ± 1.05 43.74 ± 2.79 44.68 ± 2.26 46.40 ± 2.78
MCV (fl) 52.84 ± 0.21 52.32 ± 0.30 52.02 ± 0.12 52.40 ± 0.27
MPV (fl) 5.66 ± 0.32 5.52 ± 0.65 5.28 ± 0.44 4.80 ± 0.28
MCH (pg) 15.46 ± 0.12 15.36 ± 0.12 15.70 ± 0.17 15.68 ± 0.11
MCHC (g/dl) 29.22 ± 0.21 29.32 ± 0.19 30.26 ± 0.35 29.88 ± 0.24
PDW (%) 23.02 ± 1.06 20.24 ± 1.09 22.80 ± 1.81 22.86 ± 1.13
Leukocytes (K/μl) 7.00 ± 1.34 6.64 ± 1.51 7.75 ± 1.42 7.26 ± 1.37
% Lymphocytes 74.62 ± 2.50 73.90 ± 3.08 81.94 ± 1.15 73.87 ± 3.48
% Neutrophils 20.39 ± 1.95 20.39 ± 2.29 14.93 ± 1.15 21.44 ± 2.13
% Monocytes 3.76 ± 0.31 3.81 ± 0.37 2.57 ± 0.33 2.80 ± 0.42
% Eosinophils 1.09 ± 0.37 1.57 ± 0.55 0.69 ± 0.20 1.37 ± 0.85
% Basophils 0.15 ± 0.05 0.34 ± 0.13 0.07 ± 0.03 0.52 ± 0.31
MCH, mean corpuscular hemoglobin; MCV, mean corpuscular volume; MPV, mean platelet volume; PDW, platelet distribution width; MCHC, 
mean corpuscular hemoglobin concentration.
Values are expressed as the means (± SE) for each group.













Anderson et al. Page 17
Table 3
Effects of dermal exposure to dimethyl carbonate for 28 days on total spleen cell number and of lymphocyte 
sub-populations in female B6C3F1 mice.
Dimethyl carbonate
Parameter 0% 50% 75% 100%
Spleen nucleated cell
 number (×106)
143.6 ± 17.10 116.2 ± 4.6 123.4 ± 4.8 113.6 ± 7.3
B-cell number (×106) 66.37 ± 7.7 55.92 ± 3.5 63.53 ± 2.3 54.75 ± 4.7
% of splenocytes 46.30 ± 0.89 47.97 ± 1.22 51.57 ± 1.28 47.96 ± 1.10
T-cell number (×106) 40.18 ± 1.4 37.48 ± 1.4 38.06 ± 1.2 36.80 ± 1.9
% of splenocytes 27.94 ± 0.31 27.88 ± 0.81 26.18 ± 0.73 27.47 ± 1.13
CD4+T-cell number (×106) 30.18 ± 1.43 27.48 ± 1.40 28.06 ± 1.23 26.80 ± 1.86
% of splenocytes 21.61 ± 1.32 23.77 ± 1.27 22.71 ± 0.47 23.66 ± 0.97
CD8+T-cells (×106) 15.42 ± 0.81 13.80 ± 0.60 13.00 ± 0.29 13.44 ± 1.01
% of splenocytes 11.03 ± 0.66 11.93 ± 0.38 10.58 ± 0.36 11.86 ± 0.53
Mice were dermally exposed to vehicle (acetone) or different concentrations of DMC for 28 days (times) over 2 weeks. The mice were euthanized 
24 h after the final exposure, spleens were removed, and total nucleated splenocytes counted. Numbers of B- and T-cells, and subsets of T-cells 
(CD4+ and CD8+) were enumerated.
Values represent the means (± SE) for each group.
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